PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2026The Brazilian Journal of Infectious Diseases0 citationsOpen Access

Evaluation of Outcomes in Kidney Transplant Recipients With Urinary Tract Infection Caused by Gram-Negative Bacilli: Application of the Door Model in a 10-Year Cohort

View Full Paper
GBGiulia Soska BaldisseraUniversidade Federal do Rio Grande do SulVGVinicius da Silva GregoryUniversidade Federal do Rio Grande do SulMMMurilo MartiniUniversidade Federal do Rio Grande

Key Points

  • The study aims to validate a DOOR model for assessing clinical outcomes of urinary tract infections in kidney transplant recipients.
  • Retrospective cohort study conducted from 2013 to 2023.
  • Included patients with kidney transplants and urinary tract infections due to gram-negative bacilli.
  • Matched patients with carbapenem-resistant and carbapenem-susceptible infections 1:1.
  • Primary outcome measured was a 14-day DOOR assessment.
  • Adjusted analyses utilized propensity score weighting.
  • CRGN infections showed a 14-day DOOR outcome probability of 41.3% in crude analysis.
  • Transplant-related complications occurred in 29.9% of CRGN patients compared to 15.5% of CSGN patients.
  • Subgroup analysis indicated better outcomes for those developing UTI after the first post-transplant year.
  • Patients with CRGN had worse clinical outcomes linked to higher rates of graft dysfunction.

Abstract

Urinary tract infections (UTI) caused by carbapenem-resistant Gram-negative bacilli (CRGN) represent a significant threat to kidney transplant (KT) recipients, potentially resulting in complications and graft loss. The Desirability of Outcome Ranking (DOOR) strategy allows a global, patient-centered assessment of outcomes. This study aimed to validate a DOOR model adapted specifically for KT recipients by comparing clinical outcomes of UTI caused by carbapenem-resistant versus carbapenem-susceptible Gram-negative (CSGN) bacteria. Retrospective cohort study conducted between 2013 and 2023 at a tertiary hospital in Brazil. Patients ≥18 years, with previous KT and UTI due to Gram-negative bacilli, were included. Patients with CRGN infections were matched 1:1 with CSGN controls by year of infection. The primary outcome was a 14-day DOOR. DOOR categories were defined to reflect outcome severity, including occurrence of adverse events, lack of clinical response, infectious complications, transplant-related complications (e.g., rejection, CMV infection, and graft dysfunction), and death. Adjusted analyses were performed using propensity score weighting. A total of 194 patients were included (97 CRGN and 97 CSGN). The probability of a more favorable 14-day DOOR outcome was 41.3% (95% CI: 34.2%–48.7%; p = 0.02) for CRGN in the crude analysis, and 43.4% (95% CI: 36.2%–50.9%; p = 0.08) after adjustment. Transplant-related complications occurred in 29.9% of CRGN versus 15.5% of CSGN patients. In a subgroup analysis excluding patients on baseline dialysis, the results were maintained. Patients who developed UTI after the first post-transplant year had significantly better outcomes. UTI caused by CRGN in KT recipients were associated with worse 14-day clinical outcomes in the unadjusted analysis. The higher frequency of events such as graft dysfunction contributed to these poorer outcomes. The adapted DOOR model proved to be a promising tool for global assessment of outcomes in KT recipients with UTI and may be refined and applied in different epidemiological settings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Baldissera et al. (2026) studied this question.

synapsesocial.com/papers/69b8ef12deb47d591b8c51d2https://doi.org/10.1016/j.bjid.2026.105095
Ask AI
Helpful
Bookmark
Share
View Full Paper